A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
NCT ID: NCT00428220
Last Updated: 2019-06-27
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
223 participants
INTERVENTIONAL
2007-07-31
2014-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sunitinib Malate Before and After Surgery in Treating Patients With Previously Untreated Metastatic Kidney Cancer
NCT01024205
Sunitinib Malate in Treating Patients With Small Cell Lung Cancer
NCT00953459
Sunitinib in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
NCT00451048
SU011248 in Patients With Metastatic Mucosal or Acral/Lentiginous Melanoma
NCT00577382
Study Of SU011248 In Patients With Metastatic Non-Small Cell Lung Cancer
NCT00092001
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
Sunitinib will be administered in a continuous daily dose (oral, once per day). Starting dose will be 37.5 mg daily unless the patient was on a different dose (25 mg or 50 mg daily) on the previous trial. In that case, they will begin treatment on this study at the same dose used at the end of the previous study.
The protocol now allows for patients on dosing regimens other than only continuous dosing (e.g. 4/2, etc.) to be enrolled if eligible.
sunitinib
sunitinib
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
sunitinib
sunitinib
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Emory University, Winship Cancer Institute
Atlanta, Georgia, United States
Investigational Drug Service
Atlanta, Georgia, United States
The Emory Clinic
Atlanta, Georgia, United States
Loyola University Medical Center
Maywood, Illinois, United States
University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
Siteman Cancer Center
City of Saint Peters, Missouri, United States
Siteman Cancer Center-West County
Creve Coeur, Missouri, United States
Barnes Jewish Hospital
St Louis, Missouri, United States
Washington University School of Medicine, Siteman Cancer Center
St Louis, Missouri, United States
Comprehensive Cancer Center of Nevada
Las Vegas, Nevada, United States
Comprehensive Cancer Centers of Nevada
Las Vegas, Nevada, United States
Northwest Cancer Specialists, P.C.
Portland, Oregon, United States
Northwest Cancer Specialists, P.C.
Portland, Oregon, United States
US Oncology Research and Clinical Pharmacy (Drug Shipment Only)
Fort Worth, Texas, United States
The Strelitz Diabetes Institute of Eastern Virginia Medical School
Norfolk, Virginia, United States
Instituto Oncologico de Cordoba
Nueva Cordoba, Nueva Cordoba, Argentina
Clinica Viedma
Viedma, Río Negro Province, Argentina
Centro Oncológico Rosario
Rosario, Santa Fe Province, Argentina
Centro Medico San Roque
San Miguel de Tucumán, , Argentina
Royal Brisbane & Women's Hospital
Herston, Queensland, Australia
Royal Adelaide Hospital, Department of Medical Oncology
Adelaide, South Australia, Australia
Austin Health
Heidelberg, Victoria, Australia
Royal Melbourne Hospital
Parkville, Victoria, Australia
Mount Medical Centre
Perth, Western Australia, Australia
Hopital Erasme / Gastroenterologie
Brussels, , Belgium
Cliniques Universitaires Saint Luc / Gastroentérologie
Brussels, , Belgium
Cliniques Universitaires Saint-Luc, Oncologie
Brussels, , Belgium
UZ Gasthuisberg, Department Internal Medicine - Gastroenterology - Gastro-intestinal Oncology
Leuven, , Belgium
Centre Hospitalier Universitaire de Liege
Liège, , Belgium
Algemeen Ziekenhuis Nikolaas
Sint-Niklaas, , Belgium
AZ Sint-Augustinus, Oncologisch Centrum
Wilrijk, , Belgium
Hospital São Lucas da PUCRS
Porto Alegre, Rio Grande do Sul, Brazil
Hospital Nossa Senhora da Conceicao
Porto Alegre, Rio Grande do Sul, Brazil
Centro de Oncologia do Instituto de Radiologia
São Paulo, São Paulo, Brazil
Sociedade Beneficente de Senhoras Hospital Sirio Libanes
São Paulo, São Paulo, Brazil
BC Cancer Agency - Vancouver Centre
Vancouver, British Columbia, Canada
QEII Health Sciences Centre - Nova Scotia Cancer Centre
Halifax, Nova Scotia, Canada
QEII Health Sciences Centre - Victoria General Site
Halifax, Nova Scotia, Canada
QEII Health Sciences Centre - Halifax Infirmary Site
Halifax, Nova Scotia, Canada
London Regional Cancer Program
London, Ontario, Canada
Princess Margaret Hospital
Toronto, Ontario, Canada
CHUM, Hopital Saint-Luc
Montreal, Quebec, Canada
Royal Victoria Hospital
Montreal, Quebec, Canada
Fundacion Centro de Investigacion Clinica CIC
Medellín, Anquioquia, Colombia
Hospital Universitario San Vicente de Paul
Medellín, Antioquia, Colombia
Clinica Astorga
Medellín, Antioquia, Colombia
Centre Antoine Lacassagne
Nice, Cedex 02, France
Hopital Beaujon
Clichy, Cedex, France
Groupe Hospitalier Cochin, Cancer Quest AP-HP
Paris, Cedex, France
CHU-Hôpital Jean Minjoz
Besançon, , France
Hopital Saint-Andre
Bordeaux, , France
Centre Jean Perrin
Clermont-Ferrand, , France
Polyclinique du Bois
Lille, , France
Centre Oscar Lambret
Lille, , France
Centre Leon Berard
Lyon, , France
Hopital Edouard Herriot
Lyon, , France
Chu La Timone
Marseille, , France
Clinique Hartmann
Neuilly-sur-Seine, , France
Hopital Saint-Antoine
Paris, , France
Centre Eugene Marquis
Rennes, , France
Klinik fuer Innere Medizin, Gastroenterologie, Onkologie, Endokrinologie
Bad Berka, , Germany
Universitaetsklinikum Charité, Campus Virchow Klinikum
Berlin, , Germany
eps - early phase GmbH
Jena, , Germany
Frauenaerzte Pruener Gang
Kiel, , Germany
Klinik fuer Frauenheilkunde und Geburtshilfe, Universitaetsklinikum Schleswig-Holstein
Lübeck, , Germany
Universitaetsklinikum Schleswig-Holstein, Campus Luebeck
Lübeck, , Germany
Universitaetsklinikum Giessen und Marburg, Standort Marburg
Marburg, , Germany
Rhoen Klinikum Meiningen, Gynaekologie und Geburtshilfe
Meiningen, , Germany
Frauenklinik und Poliklinik, Klinikum rechts der Isar, Technische Universitaet Muenchen
München, , Germany
Department of Clinical Oncology, Tuen Mun Hospital
Tuenmen, New Territories, Hong Kong
Queen Mary Hospital
Hong Kong, , Hong Kong
Division of Haematology/Oncology, Department of Medicine, Queen Mary Hospital,
Hong Kong, , Hong Kong
Queen Elizabeth Hospital, Department of Clinical Oncology
Kowloon, , Hong Kong
Tuen Mun Hospital, Department of Clinical Oncology
Tuen Mun, New Territories, , Hong Kong
UNIMED Medical Institute
Wan Chai, , Hong Kong
Hospital Universitario Dr. Jose Eleuterio Gonzalez Centro Universitario contra el cancer
Monterrey, Nuevo León, Mexico
Hospital Christus Muguerza del Parque
Chihuahua City, , Mexico
Cancer Care Clinic
Quezon City, Metro Manila, , Philippines
National University Hospital/Department of Heamatology-Oncology
Singapore, , Singapore
National Cancer Center/Department of Medical Oncology
Singapore, , Singapore
National Cancer Center
Goyang-si, Gyeonggi-do, South Korea
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea
Seoul National University Hospital / Department of Internal Medecine
Seoul, Republic of Korea, South Korea
Asan Medical Center, Division of Oncology, Department of Internal Medicine
Seoul, Republic of Korea, South Korea
Yeungnam University Medical Center/Department of Internal medicine
Daegu, , South Korea
Severance Hospital, Yonsei Cancer Center, Yonsei University College of Medicine
Seoul, , South Korea
Corporacio Sanitaria Parc Tauli
Sabadell, Barcelona, Spain
Fundacion Hospital Alcorcon
Alcorcón, Madrid, Spain
Complexo Hospitalario Universitario A Coruña
A Coruña, , Spain
Servicio de Oncologia
Barcelona, , Spain
Centro Oncologico Md Anderson International España
Madrid, , Spain
Hospital Clinico San Carlos
Madrid, , Spain
Hospital 12 de Octubre
Madrid, , Spain
Hospital Universitario La Paz
Madrid, , Spain
Chi Mei Medical Center, Liouying
Liouying Township, Tainan,, Taiwan, Taiwan
Chi-Mei Medical Center
YungKang City, Tainan, Taiwan, Taiwan
Chang Gung Medical Foundation, Linkou Branch
Guishanli, Taoyuan, Taiwan
Changhua Christian Hospital
Changhua, , Taiwan
Chung-Ho Memorial Hospital, Kaohsiung Medical University/Department of Surgery
Kaohsiung City, , Taiwan
Taichung Veterans General Hospital, Department of Surgery
Taichung, , Taiwan
National Taiwan University Hospital/Department of Oncology
Taipei, , Taiwan
Koo Foundation Sun Yat-Sen Cancer Center, Div. of Hematology/Oncology
Taipei, , Taiwan
Taipei Veterans General Hospital
Taipei, , Taiwan
Division of Surgery and Oncology
Liverpool, Merseyside, United Kingdom
Deparment of Cardiology
Glasgow, , United Kingdom
The Beatson West of Scotland Cancer Centre
Glasgow, , United Kingdom
Dainton Building
Leeds, , United Kingdom
St James' Institute of Oncology
Leeds, , United Kingdom
Management Offices, 4th Floor, Thomas Guy House
London, , United Kingdom
Royal Marsden Hospital
London, , United Kingdom
Department of Medical Oncology
Manchester, , United Kingdom
Cardiology Department, Wythenshawe Hospital
Manchester, , United Kingdom
Nottingham City Hospital
Nottingham, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2006-006538-16
Identifier Type: EUDRACT_NUMBER
Identifier Source: secondary_id
A6181114
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.